Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FALSE CLAIMS ACT—N.D. Ind.: Court prescribes trial for hospital facing FCA allegations in connection with 340B diversion, retaliation
    • CONDITIONS OF PARTICIPATION—DAB DECISIONS: Facility locked, unstaffed, during posted hours deemed not ‘operational’
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—FINAL RULES: Adjustment to the 2026 Aggregate Production Quota for d,lAmphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sale) Pursuant to 21 U.S.C. 826(h)
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COVERAGE—GAO REPORTS: Medicare, Medicaid beneficiaries generally had opioid overdose reversal medication coverage
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • DRUGS AND BIOLOGICS—FDA GUIDANCE NOTICES: Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency; Guidance for Industry and Food and Drug Administration Staff; Availability
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—DOJ Fraud Division launches Whistleblower Rewards Program offering fast-track payments for fraud tips
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICARE PART C / MEDICARE ADVANTAGE—E.D. Pa.: Federal Arbitration Act equitable-relief carve-out excludes challenges to Medicare Advantage reimbursement policy
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • QUALITY OF CARE—DAB DECISIONS: Medicare accident-hazard rules require pureed meals free of chunks and support immediate-jeopardy penalties
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—FINAL RULES: Adjustment to the 2026 Aggregate Production Quota for d,lAmphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sale) Pursuant to 21 U.S.C. 826(h), (Nov 12, 2026)

    By WK Editorial Staff

    The DEA is adjusting the 2026 aggregate production quota for the schedule II controlled substances d,lamphetamine, d-amphetamine (for sale), hydromorphone, and methylphenidate (for sale).

    The DEA adjusted 2026 quotas for schedule II drugs—d,l-a ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use